期刊文献+

2型糖尿病患者冠状动脉病变严重程度与血清胱抑素C相关性研究 被引量:2

The relationship between coronary artery disease in type 2 diabetic patients and serum cystatin C
在线阅读 下载PDF
导出
摘要 目的 探讨2型糖尿病患者冠状动脉病变程度与血清胱抑素C(Cys C)的关系.方法 选取2011年10月至2013年10月2型糖尿病患者180例,经冠状动脉造影分为冠心病组与非冠心病组,比较两组血清Cys C的差异;同时按冠心病严重程度分为单支病变组、双支病变组及多支病变组,比较三组间血清Cys C水平的差异.应用多因素非条件Logstic逐步回归分析法分析2型糖尿病合并冠心病的危险因素.结果 血清Cys C水平糖尿病非冠心病组[(0.83±0.16)mg/L]低于糖尿病冠心病组[(1.06±0.14)mg/L].随着冠心病严重程度的加重,血清Cys C水平不断升高,甘油三酯、糖化血红蛋白、血清Cys C与冠心病存在相关性,血清Cys C为糖尿病合并冠心病的独立危险因素(OR=1.230).结论 血清Cys C水平与2型糖尿病患者冠心病的发生、发展及预后密切相关,可能成为冠心病的一项重要预测指标. Objective To investigate the relationship between extent of coronary artery disease and serum cystatin C (Cys C) in patients with type 2 diabetic.Methods From 2011 October to 2013 October 180 cases of patients with type 2 diabetes mellitus were enrolled,and were divided into CHD group and non CHD group according the results of coronary angiography.The difference of serum cystatin C was compared between the two groups;according to the severity of coronary lesions,the patients were divided into single,double branch lesions and multi vessel disease group,the difference of serum cystatin C level was compared among three groups.The risk factors of type 2 diabetes with coronary heart disease were analyzed by non condtional Logistic regression analysis of multifactor.Results The serum Cys C level in diabetic non CHD group [(0.83±0.16)mg/L was lower than that of diabetic coronary heart disease group (1.06±0.14)mg/L].With the aggravation of the severity of coronary artery disease,serum cystatin C levd increased.The glycosylated hemoglobin,triglyceride,serum cystatin C were correlated with coronary heart disease,and serum cystatin C was independent risk factors of diabetes mellitus complicated with coronary heart disease(OR=l.230).Conclusion The serum Cys C level may relate with the occurrence,development and prognosis of type 2 diabetic with coronary heart disease,may be an important predictor of coronary heart disease.
作者 赖杰
出处 《中国心血管病研究》 CAS 2014年第7期595-597,共3页 Chinese Journal of Cardiovascular Research
关键词 糖尿病 2型 血清胱抑素C 冠状动脉疾病 Type 2 diabetes Serum cystatin C Coronary heart disease
作者简介 通讯作者:赖杰,E—mail:laijie19790811@163.com
  • 相关文献

参考文献8

  • 1Nagesh CM, Roy A. Role of biomarkers in risk stratification of a- cute coronary syndmme. Indian J Med Res, 2010,132 : 627-633.
  • 2Taglieri N, Koenig W, Kaski JC. Cystatin C and cardiovasculao risk. Clin Chem, 2009,55 : 1932-1943.
  • 3Brown TM, Billner V. Bi, markers of athemsclerosis:clnical ap- plications. Curr Cardiol Rep, 2008,10 : 497-504.
  • 4Ni L, Lu J, Hou LB, et al. Cystatin C, associated with hemor- rhagic and ischemic stroke, is a strong predictor of the risk of cardiovascular events and death in Chinese. Stroke,2007,38: 3287-3288.
  • 5Luc G, Bard JM, lesueur C, et al. Plasma Cystatin C and devel- opment of coronaryheart disease: The PRIME Study. Atheroscle- rosis, 2006,185 : 375-380.
  • 6Ogawa Y, Goto T, Tamasawa N, et al. Serum eystatin c in dia- betic patients. Not only an indicator for renal dysfunction in pa- tients with overtnephmpathy but also a predictor for cardiovascu- lar events in patients without nephropathy. Diabetes Res Clin Praet, 2008,79 : 357-361.
  • 7郭守玉,龙明智.冠心病患者胱抑素C水平与冠状动脉造影Gensini评分的相关性[J].检验医学与临床,2012,9(4):385-386. 被引量:35
  • 8孙磊,杨志健,贾恩志.胱抑素C与冠心病的相关性研究[J].南京医科大学学报(自然科学版),2009,29(5):702-706. 被引量:25

二级参考文献20

  • 1J Am Coll Cardiol,张伟丽.CRP与斑块破裂有关[J].中国分子心脏病学杂志,2005,5(3):546-546. 被引量:78
  • 2董巧玲,刘俊.急性心肌梗死患者血清Cystatin C的变化[J].中国心血管病研究,2007,5(1):27-29. 被引量:19
  • 3McMahan CA,Gidding SS,McGill HC. Coronary heart disease risk factors and atherosclerosis in young people[J]. J Clin Lipidol,2008,2(3) : 118-126.
  • 4Simonsen O,Grubb A,Thysell H. The blood serum concentration of Cystatin C (gamma-trace)as a measure of the glomerular filtration rate [J]. Scand J Clin Lab Invest, 1985,45 (2) :97-101.
  • 5Koenig W,Twardella D, Brenner H, et al. Plasma concentration of cystatin c in patients with coronary heart disease and risk for secondary cardiovascular events:more than simply a marker of glomerular filtration rate [J ]. Clin Chem, 2005,51 (2) : 321-327.
  • 6Noto D, Cefalu AB, Barbagallo CM, et al. Cystatin C levels are decreased in acute myocardial infarction:effect of cystatin C G73A gene polymorphism on plasma levels[J]. Int J Cardiol, 2005,101 (2) : 213-217.
  • 7Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease [J]. Am J Cardio, 1983,51 (3) : 606.
  • 8Dharnidharka VR, Kwon C,Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function:a meta-analysis [J]. Am J Kidney Dis,2002,40 (2) :221-226.
  • 9Luc G,Bard JM,Lesueur C,et al. Plasma cystatin-C and development of coronary heart disease:The Prime Study [ J ]. Atherosclerosis, 2006,185 (2) : 375-380.
  • 10Ix JH,Shlipak MG,Chertow GM,et al. Association of cystatin C with mortality,cardiovascular events,and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study [J].Circulation, 2007,115(2) : 173-179.

共引文献53

同被引文献17

引证文献2

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部